BioSpace News Archive

Heron Therapeutics, Inc. announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2019 at 5:20 p.m. GMT at the Waldorf Hilton London hotel.

Sierra Oncology, Inc. announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company entitled “Building Momentum for Patients with Myelofibrosis” at the Jefferies 2019 London Healthcare Conference in London, United Kingdom.

The patent relates to Bioasis’ P97 conjugates with therapeutic agents where the P97 has the ability to transport the agent across the BBB.

Advanced GMP-compliant manufacturing capability

BD announced that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 6:20 a.m. ET.

RJH Biosciences Inc. has announced a grant from the Bill & Melinda Gates Foundation to develop a new device to enable ‘Immunotherapy On-the-Go’. RJH Biosciences Inc., a privately held biotech company in Edmonton, Alberta, will pursue a Phase I Project under the Grand Challenges Explorations initiative to develop a new mode of immunotherapy.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) of Twirla® (levonorgestrel/ethinyl estradiol) transdermal system, an investigational combined hormonal contraceptive patch, from November 16, 2019 to February 16, 2020.

MedCerts, a leader in online career certification training, is working with American Job Centers across the country to train individuals for in-demand industries

KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and financial results for the quarter ended September 30, 2019.

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the Stifel 2019 Healthcare Conference on Wednesday, November 20th, at 1:15 pm Eastern Time.